United States · FDA National Drug Code directory
DABIGATRAN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60687-974_56a62694-97c0-fc7d-e063-6294a90ad22d
- Product NDC
- 60687-974
- Form
- CAPSULE
- Composition / generic term
- DABIGATRAN ETEXILATE
- Labeler
- American Health Packaging
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260625
- Source listing expiry
- 20271231
Source-listed ingredients
- DABIGATRAN ETEXILATE MESYLATE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 20 BLISTER PACK in 1 CARTON (60687-974-32) / 1 CAPSULE in 1 BLISTER PACK (60687-974-33) · 60687-974-32
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →